Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase III trial of Ampligen for the treatment of CFS now underway

Aug. 14, 1998

New antimigraine drug candidate discussed by Pierre Fabre at IUPHAR meeting

Aug. 13, 1998

Antidepressant efficacy established with new addition to the Ampakine family

Aug. 13, 1998

Joint research project will evaluate ABS-103 for the treatment of epilepsy

Aug. 13, 1998

Sepracor patents single-isomer form of zopiclone for treatment of sleep disorders

Aug. 13, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

ADIR discovers new compounds with affinity for imidazoline receptors

Aug. 12, 1998

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Aug. 11, 1998

Studies with spheron-targeted AD treatment candidate yield promising results

Aug. 11, 1998

MABE: a new enkephalin analogue with analgesic potential

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...